Correlation Between AusCann Group and Alterola Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AusCann Group and Alterola Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AusCann Group and Alterola Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AusCann Group Holdings and Alterola Biotech, you can compare the effects of market volatilities on AusCann Group and Alterola Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AusCann Group with a short position of Alterola Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of AusCann Group and Alterola Biotech.

Diversification Opportunities for AusCann Group and Alterola Biotech

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between AusCann and Alterola is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding AusCann Group Holdings and Alterola Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alterola Biotech and AusCann Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AusCann Group Holdings are associated (or correlated) with Alterola Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alterola Biotech has no effect on the direction of AusCann Group i.e., AusCann Group and Alterola Biotech go up and down completely randomly.

Pair Corralation between AusCann Group and Alterola Biotech

If you would invest  0.38  in AusCann Group Holdings on November 3, 2024 and sell it today you would earn a total of  0.00  from holding AusCann Group Holdings or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy2.38%
ValuesDaily Returns

AusCann Group Holdings  vs.  Alterola Biotech

 Performance 
       Timeline  
AusCann Group Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AusCann Group Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, AusCann Group is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Alterola Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Alterola Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Alterola Biotech demonstrated solid returns over the last few months and may actually be approaching a breakup point.

AusCann Group and Alterola Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AusCann Group and Alterola Biotech

The main advantage of trading using opposite AusCann Group and Alterola Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AusCann Group position performs unexpectedly, Alterola Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alterola Biotech will offset losses from the drop in Alterola Biotech's long position.
The idea behind AusCann Group Holdings and Alterola Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope